Bio
January 20, 2021

NuroKor appoints Chief Commercial Officer to lead growth across consumer markets

Catherine Kelly
Public Relations Director

NuroKor is delighted to welcome senior global sales and marketing professional William Ripley, who joins as Chief Commercial Officer – Consumer Markets, to help to lead the company’s growth across multiple channels and its vertical markets.

With a background spanning more than 20 years heading business growth and bringing innovative technology to market, William will be focusing on defining and delivering the fast-growing company’s commercial strategy.

With strong expertise in consumer electronics, mobile and wearable technologies and telecommunications, William specialises in driving growth through successful product innovation and go-to-market execution across B2C and B2B channels. He brings extensive experience and success in UK and EMEA markets.

“I have always been passionate about how technology can enhance our wellbeing (and that of our planet). NuroKor’s consumer medical wearables, which reduce pain and accelerate recovery, are a fantastic example. I was energised by Rick’s clarity of vision and determination to disrupt the healthcare market. I am really excited to be able leverage my experience in growing businesses globally to help NuroKor to deliver its ambition.”

After starting his career at healthcare technology pioneer Philips, he went on to lead key projects for companies including Motorola Mobility (Google), Three.co.uk (CK Hutchison) and Brightstar (Softbank).

William has experience with different business models covering traditional hardware sales and subscription-based services. And his international background allows him to comfortably navigate different business cultures and do business in several languages to deliver results.

William is also looking forward to being a part of NuroKor’s fast-paced growth. He said,

“I see NuroKor playing a key role in democratising the use of bioelectronics as a standard medicine across the globe. Growing consumer awareness of the advantages of bioelectronics versus drugs and NuroKor’s continuous product and service innovation, will be catalysts for strong business growth.”

About NuroKor:

Founded in 2018, NuroKor is a company committed to the development of bioelectronic technologies. NuroKor develops and formulates programmable bioelectronic software as electroceuticals for clinical and therapeutic applications, in a range of easy to use, wearable technology. It provides the highest-quality, medically regulated products, delivering personalised pain relief and recovery support and rehabilitation to patients.